Juan Pedro Caraça-Valente Hernández

Identifying patterns to uncover the importance of biological pathways on known drug repurposing scenarios

The paper identifies drug repurposing cases based on biological pathways (DREBIOP) and finds they involve more pathways and lower gene-disease association values compared to target-based repurposing.

Orphan Drugs and Rare Diseases: Unveiling Biological Patterns through Drug Repurposing

This paper examines the evolution of orphan drug development and identifies biological patterns in rare diseases treated with repurposed drugs.

Drug repositioning with gender perspective focused on Adverse Drug Reactions

This study investigates gender differences in drug repositioning by analyzing adverse drug reactions, with a focus on rare diseases.